Genital Warts
Genital warts are caused by human papillomavirus (HPV). The types of HPV that cause genital warts are usually spread by direct skin-to-skin contact during vaginal, anal, or possibly oral sex with someone who has this infection.
Vaccines That Can Prevent STIs
One important prevention tool against sexually transmitted infections is vaccination. Currently, vaccines are available to protect against infection with HPV, hepatitis A and hepatitis B.
NGU, or Nongonoccocal Urethritis
Nongonococcal urethritis—or NGU—is an infection of the urethra caused by germs other than gonorrhea. The most common cause is chlamydia.
Preventing HIV with Just Two Shots a Year? A New Study Shows This is Possible
Remarkable results in a Phase III PrEP trial with women and adolescent girls in Africa—two injections per year effectively prevented all HIV infection.
New Option for Cervical Cancer Screening — Self Collected Samples
The FDA recently approved HPV testing using self-collected samples. Experts hope allowing people to collect their own samples will increase screening rates.
New CDC Guidelines Offer Recommendations On Doxy PEP
Doxy PEP involves taking an oral antibiotic after condomless sex to prevent bacterial STIs. Research has shown that this can reduce the possibility of contracting chlamydia by 88%, syphilis by 87%, and gonorrhea by 55%.
New Guidelines on Syphilis Testing in Pregnancy
The American College of Obstetricians and Gynecologists released new guidelines recommending that all pregnant people be screened for syphilis three times during pregnancy.
Vampire Facials Confirmed as Cause of At Least Three HIV Infections
A joint investigation by the CDC and the New Mexico Health Department has confirmed that an unlicensed medi-spa is responsible for at least three cases of HIV.
HPV-Related Cancer in Men — Stories from Survivors
We know that one important way to raise awareness about HPV-related cancer in men is by sharing stories of those who have experienced it. Here we share stories from three men on their experiences with HPV-related cancer.
An Experimental Vaccine for Chlamydia Shows Promise in Early Study
A Phase 1 trail for a possible new chlamydia vaccine had encouraging results. Chlamydia is one of the most common STIs worldwide—a vaccine could dramatically change this landscape.